Page last updated: 2024-08-21

hematoxylin and Adrenal Cortex Cancer

hematoxylin has been researched along with Adrenal Cortex Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolla, S; Duregon, E; Molinaro, L; Papotti, MG; Righi, L; Sapino, A; Terzolo, M; Ventura, L; Volante, M1

Other Studies

1 other study(ies) available for hematoxylin and Adrenal Cortex Cancer

ArticleYear
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2014, Volume: 27, Issue:9

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Eosine Yellowish-(YS); Female; Hematoxylin; Histones; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Mitotic Index; Phosphorylation; Prognosis; Survival Rate; Young Adult

2014